COVID-19 Research

  • Home /
  • Research /
  • COVID-19 /
  • AP-1 and NF-jB synergize to transcriptionally activate latent HIV upon T-cell receptor activation

AP-1 and NF-jB synergize to transcriptionally activate latent HIV upon T-cell receptor activation

Principal Researchers: Joseph Hokello Completed

Duration: Aug-2020
Research Objectives:

Latent HIV-1 proviruses are capable of reactivating productive lytic infection, but the precise molecular mechanisms underlying emergence from latency are poorly understood. In this study, we determined the contribution of the transcription factors NF-jB, NFAT, and AP-1 in the reactivation of latent HIV following T-cell receptor (TCR) activation using Jurkat T-cell clones harboring single latent HIV proviruses. Our findings demonstrate that during reactivation from latency, NF-jB enhances HIV transcription while NFAT inhibits it by competing with NF-jB for overlapping binding sites on the HIV long terminal repeat (LTR). We have also demonstrated for the first time the molecular contribution of AP-1 in the reactivation of HIV from latency, whereby AP-1 synergizes with NF-jB to regulate HIV transcriptional elongation following TCR activation

Nature of Research output:

Research Article